Voyager Therapeutics is trading at $1.91, up +9.78% in after-hours trading, with no clear company-specific announcement or news identified to explain the rise.
- Shares closed the regular session at $1.74.
- The CEO succession plan was announced on October 21, but available reporting does not establish it as the catalyst for this move.
- Healthcare and biotechnology shares were lower Friday afternoon, while major indices were mixed, offering no clear explanation.